Omnicell, Inc. — News

OMCL heads into Q2 earnings with OmniSphere adoption, Connected Devices execution and recurring revenue growth ahead of July 30 results.

zacks.com - 2026-07-21 12:36:08

Omnicell is advancing its autonomous pharmacy vision and expanding SaaS offerings, but tariffs and fierce competition could test its growth path.

zacks.com - 2026-07-09 15:21:05

Shares of Omnicell OMCL have rallied 52.6% over the past year, significantly outperforming the industry's 20.8% fall and the S&P 500 composite's 23.9% gain.

zacks.com - 2026-07-07 11:01:13

FORT WORTH, Texas--(BUSINESS WIRE)--Nnamdi Njoku appointed President of Omnicell leading global operations & innovation strategy; Randall Lipps continues as CEO, Chairman of the Board.

businesswire.com - 2026-07-01 08:15:00

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-06-30 10:41:09

Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com - 2026-06-26 12:40:16

Investors need to pay close attention to OMCL stock based on the movements in the options market lately.

zacks.com - 2026-06-24 11:41:08

Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-06-10 12:41:11

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-10 10:41:15

Omnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-06-09 17:32:11

Omnicell is rated Buy, with Q1 results showing structural margin improvement and a 660 bps operating margin jump. Q1 revenue grew 15% Y/Y to $310M, with non-GAAP EPS of $0.55 beating guidance by 53% and free cash flow tripling to $39M. Management raised FY 2026 EBITDA guidance, expects margin expansion to outpace revenue growth, and continues share repurchases.

seekingalpha.com - 2026-06-09 08:10:34

FORTH WORTH, Texas--(BUSINESS WIRE)--Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business.

businesswire.com - 2026-06-08 08:30:00

Robotics stocks like ABB gain traction as 2026 marks a surge in AI-driven automation, new cobots and strategic deals shaping the sector's next growth wave.

zacks.com - 2026-06-05 12:21:08

The average of price targets set by Wall Street analysts indicates a potential upside of 40.6% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

zacks.com - 2026-06-05 10:57:14

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-06-05 10:51:17

On June 04, 2026, Omnicell Inc (OMCL) shares rose 4.1% to a current price of $43.62. This performance comes amid a volatile trading period, with the stock's 52-

gurufocus.com - 2026-06-04 20:43:00

OMCL rides on SaaS growth, Autonomous Pharmacy adoption and expansion plans, but rising costs and competition could test its momentum.

zacks.com - 2026-06-04 11:02:09

After losing some value lately, a hammer chart pattern has been formed for Omnicell (OMCL), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

zacks.com - 2026-06-04 10:56:14

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026.

businesswire.com - 2026-06-02 16:01:00

Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-05-28 12:36:33

OMCL shares soar 57.3% in a year as SaaS growth, Autonomous Pharmacy momentum and OmniSphere adoption boost outlook.

zacks.com - 2026-05-25 10:06:08

Omnicell, Inc. (OMCL) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, OMCL's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

zacks.com - 2026-05-22 10:56:11

The average of price targets set by Wall Street analysts indicates a potential upside of 39.9% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

zacks.com - 2026-05-20 10:55:19

Omnicell, Inc. (OMCL) Shareholder/Analyst Call Prepared Remarks Transcript

seekingalpha.com - 2026-05-19 18:00:44

Omnicell, Inc. (OMCL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-12 16:21:15

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-05-07 10:50:22

Does Omnicell (OMCL) have what it takes to be a top stock pick for momentum investors? Let's find out.

zacks.com - 2026-05-05 13:01:19

Doximity, Veeva and Omnicell ride surging GenAI adoption in healthcare, tapping digital demand despite market pressure and rising cybersecurity risks.

zacks.com - 2026-05-04 14:20:15

Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

zacks.com - 2026-05-04 13:20:35

The mean of analysts' price targets for Omnicell (OMCL) points to a 41.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

zacks.com - 2026-05-04 10:56:15

OMCL posts Q1 earnings and revenue beat with surging margins and strong demand, sending shares sharply higher after results.

zacks.com - 2026-05-01 09:05:28

Omnicell provides automation and software solutions to streamline medication management for healthcare systems and pharmacies.

fool.com - 2026-04-29 11:38:05

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-04-29 10:42:34

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer.

businesswire.com - 2026-04-29 08:00:00

Analysts underestimated its ability to grow revenue and profitability in the first quarter. Management also raised certain guidance items, including adjusted profitability.

fool.com - 2026-04-28 22:06:31

On April 28, 2026, Omnicell Inc (OMCL) shares rose 20.9% to a current price of $45.51. This sharp increase follows a 52-week range where the stock has experienc

gurufocus.com - 2026-04-28 18:23:00

Investors looking for stocks in the Medical Info Systems sector might want to consider either Omnicell (OMCL) or Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com - 2026-04-28 12:41:42

Omnicell, Inc. (OMCL) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-28 11:02:37

Omnicell (OMCL) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.26 per share a year ago.

zacks.com - 2026-04-28 08:55:27

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces First Quarter 2026 Financial Results.

businesswire.com - 2026-04-28 06:30:00